Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenji Watababe
Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Related publications
Adalimumab for Endoscopic and Histopathological Mucosal Healing in Paediatric Patients With Moderate to Severe Crohn’s Disease
Przeglad Gastroenterologiczny
Gastroenterology
Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience
Przeglad Gastroenterologiczny
Gastroenterology
Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Adalimumab Reduces Extraintestinal Manifestations in Patients With Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Advances in Therapy
Medicine
Pharmacology
Association of Sleep Quality and Mucosal Healing in Patients With Inflammatory Bowel Disease in Clinical Remission
Annals of Gastroenterology
Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?
Digestive Diseases and Sciences
Physiology
Gastroenterology
Exclusive Enteral Nutrition and Mucosal Healing in Newly Diagnosed Children With Crohn’s Disease: Comparison of Clinical Parameters, Biomarkers and Mucosal Microbiome Between Responders and Non-Responders
Dental Caries, Prevalence and Risk Factors in Patients With Crohn’s Disease
PLoS ONE
Multidisciplinary
Early Anti-TNF/Immunomodulator Therapy Is Associated With Better Long-Term Clinical Outcomes in Asian Patients With Crohn’s Disease With Poor Prognostic Factors
PLoS ONE
Multidisciplinary
